TUESDAY, Feb. 4, 2020 -- If you don't need insulin, you probably haven't paid much attention to its skyrocketing cost, but new research shows that exorbitant drug pricing eventually affects everyone.
The study found that in 2017, Medicare spent nearly $8 billion on insulin. The researchers said that if Medicare were allowed to negotiate drug prices like the U.S. Department of Veterans Affairs (VA) can, Medicare could save about $4.4 billion just on insulin.
MONDAY, Jan. 27, 2020 -- Hundreds of black men recently discovered they could get more than a trim at their local barbershops. They were offered diabetes testing, too.
A new study offered customers diabetes screenings at eight New York City barbershops. Among those who took the test, 10 percent learned they had average blood sugar levels that indicated type 2 diabetes. And almost 30% appeared to have prediabetes.
MONDAY, Dec. 9, 2019 -- Skyrocketing prices and insurance limits are driving many people with diabetes to seek medications and supplies from an underground supply chain, a new study found.
"The cost of insulin, which is required in type 1 diabetes and a subset of type 2 diabetes, has increased substantially over the last decade. As the price of insulin rises and insurance premiums and deductibles go up, too, the situation has become untenable," said the study's lead author, Michelle Litchman. She is a nurse practitioner and assistant professor at the University of Utah College of Nursing, in Salt Lake City.
MONDAY, Dec. 16, 2019 -- Store-bought chicken nuggets, jelly donuts and energy bars may taste delicious. But a large, new study warns that the more of these and other highly processed foods you consume, the greater your risk for type 2 diabetes.
Every 10% increase in the amount of "ultra-processed" food translated into a 15% increase in the risk for developing diabetes, according to the French study.